www.cochrane.it Open in urlscan Pro
99.83.231.148  Public Scan

Form analysis
0 forms found in the DOM

Text Content

Skip to main content
 * English
 * Italiano


TOP MENU

 * Cochrane.org
 * Cochrane Library
 * Admin

COCHRANE
ITALY

Trusted evidence.
Informed decisions.
Better health.




AGGREGATOR


COCHRANE SEEKS INFORMATION PRODUCT SPECIALIST

Cochrane News
2 years 1 month ago

Specifications: Permanent Part time (0.5 FTE)
Salary: £43,000 per annum full time equivalent (pro rata to part time hours)
Location: Ideally based in the UK, Germany or Denmark. Candidates from the rest
of the world will be considered; however, Cochrane’s Central Executive Team is
only able to offer consultancy contracts outside these countries (1-year
fixed-term contracts)
Application Closing Date:  14 November 2022

Cochrane is a charity and a global, independent network of health practitioners,
researchers, patient advocates and others, responding to the challenge of making
vast amounts of research evidence useful for informing decisions about health.
They do this by synthesising research findings to produce the best available
evidence on what works. Their work has been recognised as the international gold
standard for high quality, trusted information.

The core purpose of this role is to advise and contribute to the development of
Cochrane information products and deliver on key projects for the Publishing &
Technology Directorate (P&T).

The majority of Cochrane Central Executive staff are located in London, UK,
however flexible locations are possible for the right candidate. Please note,
however, that we are only able to offer consultancy contracts outside of the UK,
Germany or Denmark.

Cochrane welcomes applications from a wide range of perspectives, experiences,
locations and backgrounds; diversity, equity and inclusion are key to their
values.

We will consider extended notice periods if required for applicants who wish to
honour existing contracts. We fully support remote and flexible working
arrangements.  

How to apply

 * For further information on the role and how to apply, please click here. 
 * The deadline to receive your application is by 14 November 2022.  
 * The supporting statement should indicate why you are applying for the post,
   and how far you meet the requirements, using specific examples.
 * Note that we will assess applications as they are received, and therefore may
   fill the post before the deadline.
 * Read our Recruitment Privacy Statement

Tuesday, November 1, 2022 Category: Jobs
Lydia Parsonson


MAKING HEALTH DECISIONS: SARAH’S STORY

Cochrane News
2 years 1 month ago

Healthcare decision making can be complex – learn from Sarah’s personal story
and make use of Cochrane resources.

Evidence-based healthcare is the integration of the best research evidence with
clinical expertise and patient values. It is often represented with these three
elements in a Venn diagram with these three equally important elements. However,
decision making in healthcare isn’t always so neat and uncomplicated.  Cochrane
systematic reviews contribute to the best available, current, valid, and
relevant evidence in this process. Cochrane is also committed to helping others
understand evidence-based healthcare and the role of evidence.

Sarah Chapman, a former nurse with a long career in health research, had
progressive hearing loss since early adulthood. Recently she was faced with a
life changing decision if she would like to go ahead with an optional cochlear
implant. In this video with illustrations by Karen Morley, Sarah talks us
through her personal story of healthcare decision making and how evidence and
other factors fit into her thinking.



 



Sarah explains, “We are messy creature full of messy emotions, living complex
lives, and it's in that space that we make our healthcare decisions.
Understanding evidence and learning to spot which health information is
trustworthy is important to all patients and caregivers – and Cochrane has the
resources that can help with this.” You can learn more about Sarah’s in her
personal blog, ‘From Ear to Eternity.’

Cochrane has a long and rich history of collaborating with healthcare consumers
(patients, carers, and the public). Presenting our evidence in a way that is
useful for people making decisions about healthcare and advocating for evidence
in health and care is an important part of our work.

Cochrane’s Evidence Essentials is a free introduction to Evidence Based
Medicine, clinical trials, systematic reviews, and how to use evidence when
making decisions about your health. It was co-produced with patients and
caregivers and it is presented a interactive and accessible manner.



Catherine Spencer, Cochrane CEO, says “For Cochrane to achieve its vision,
producing high quality reviews of health evidence isn’t enough. Cochrane aspires
to a world where all health decisions are informed by high-quality evidence –
which means people need to first understand evidence and how to use it. As
Sarah’s story shows, making health decisions can be complex. Cochrane’s Evidence
Essentials helps people understand health evidence and how to use it. We hope
that anyone new to the world of evidence-based healthcare will find this
resource indispensable.”

 * View the free online resource ‘Cochrane Evidence Essentials’
 * Get involved in Cochrane’s work as a patient or carer

Friday, January 19, 2024 Category: The difference we make
Muriah Umoquit


FEATURED REVIEW: SUPPORT FOR BREASTFEEDING MOTHERS

Cochrane News
2 years 1 month ago
Wednesday, October 26, 2022
Lydia Parsonson


HOW TO COMMUNICATE SCIENTIFIC UNCERTAINTY: A LIFEOLOGY AND COCHRANE
COLLABORATION

Cochrane News
2 years 1 month ago

Sometimes people avoid talking about uncertainty in scientific findings…but they
shouldn't! Gain insights and practical advice on how to communicate uncertainty
in this free resource.

Science is complicated and inherently uncertain – it’s hard for scientists and
researchers to know how to talk with diverse audiences about this. We are
excited for the launch of ‘How to communicate scientific uncertainty’ – a free
resource directed at communication professionals and scientists and researchers
sharing their work.

Lifeology’s tagline is ‘The place where science and art converge’. They offer a
platform that brings together scientists, artists, and storytellers to help
people better understand and engage with science, health information, and
research. One of the main ways they meet their objectives is through beautifully
illustrated, evidence-informed, bite-sized ‘flashcard’ courses about science and
health-related topics aimed at the general public and students. 



“Drawing on experiences of the COVID-19 pandemic, Cochrane Convenes brought
together leaders from across the world to explore and then recommend the changes
needed in evidence synthesis to better prepare for and respond to future global
health emergencies,” explains Cochrane's Editor in Chief, Dr Karla
Soares-Weiser. “The Cochrane Convenes Report has a strong call for action for
the research community to communicate scientific uncertainty better – this
Lifeology course is a fantastic resource to address this.”



Author Nicole Kelp from Colorado State University says, “Uncertainty is
complicated for all humans to handle, myself included! It was helpful to
consider science communication from this empathic perspective while writing this
course.” The Harding Centre for Risk Literacy reviewed a pre-final version. The
course was reviewed multiple times by Muriah Umoquit, Senior Communications
Officer at Cochrane.



This course has 43 cards illustrated beautifully by Jordan Hunter who uses the
analogy of a Park Ranger helping people navigate the terrain with signage. “This
project was a fun one to work on, “says Jordon. “The imagery in this course
highlights the diversity of audiences and instead of text, I used symbols in
speech bubbles so that the course can be easily translated.”




"Science communication thrives through collaboration among scientists, topic
thought leaders, communication professionals, and creative visionaries like
storytellers and artists," emphasized Muriah Umoquit, Senior Communications
Officer at Cochrane and reviewer for this course. "It was great to join forces
once again with Lifeology. This is the third collaboration with Lifeology,
following the creation of the impactful resources ‘What is an infodemic and how
can we prevent it?’ and ‘How to talk about vaccines when you’re not an expert’.
We are thrilled to present our latest endeavor: a free resource on communicating
scientific uncertainty. This invaluable resource is packed with practical advice
and utilizes accessible language, empathetic storytelling, and relatable
imagery. Join us and explore its enlightening content today!"


View the Lifeology course 'how to communicate scientific uncertainty' in:

 * English
 * Malay 

Learn more about Lifeology:

 * Interview with Lifeology
 * Lifeology website
 * Lifeology on Twitter
 * Lifeology on Instagram
 * Lifeology on Slack

Wednesday, May 31, 2023
Lydia Parsonson


COCHRANE FRAMEWORK FOR ENGAGEMENT AND INVOLVEMENT OF PATIENTS, CARERS, AND THE
PUBLIC

Cochrane News
2 years 1 month ago

Cochrane's framework to 2027 builds on existing work leading to consumer
involvement throughout the entire process of research and dissemination of
Cochrane evidence. 

Healthcare consumers (patients, carers, and the public) play a vital role in
making sure that Cochrane evidence addresses important questions and is
produced, presented, and made available in a way that’s useful for people making
difficult decisions about healthcare. 

Our consumer volunteers are a vital part of our evidence community, and we thank
them for contributing their time, skills and lived experience to the
organisation. 

Cochrane supports consumer involvement and engagement in health research because
it promotes transparency, accountability, and trust in the way that research is
produced; results in evidence that addresses consumers’ needs; reduces waste in
research; improves the translation of research into policy and practice;  leads
to improved benefits for health systems and better outcomes for patients; is
consistent with current health research approaches; and is expected or mandated
by our funders, partners, and consumers themselves.

Cochrane's framework for consumer engagement and involvement to 2027 is a result
of significant involvement of stakeholders: a task group, consultations,
surveys, prioritisation exercises, and drawing on central strategies and
previous work with consumers.

We would like to thank all those people who contributed to creating this
ambitious vision and we look forward to the work ahead to make this a reality. 



Richard Morley, Cochrane’s Consumer Engagement Officer, explains; “Cochrane has
a long and rich history of collaborating with healthcare consumers. The Cochrane
Consumer Network has played a formal role since 1995 with over 2,000 members and
2 Consumer Executives serving on the Cochrane Council. This framework will help
guide Cochrane’s work to 2027; upscaling our existing efforts and ensure
consumers are embedded and central to our work.”





The framework has five elements:

 1. Engagement - a programme of communication about health research, evidence
    dissemination, recruitment and learning that helps more people use evidence
    in health decision making.
 2. Co-production - increase the number of reviews prioritised and that involve
    consumers in the evidence production process to ensure that reviews are
    aligned with users’ needs and support consumer involvement in the governance
    of Cochrane.
 3. Accessibility - a programme to improve health literacy amongst healthcare
    consumers that covers understanding evidence, health research, critical
    appraisal, and shared decision making, whilst working to make Cochrane
    evidence more accessible.
 4. Partnership - establish a range of international strategic partnerships,
    including patient groups, to develop engagement, co-production, advocacy and
    health literacy activities leading to the dissemination of Cochrane evidence
    and improved engagement and involvement.
 5. Evaluation and reporting - establish an observatory in order to ensure
    Cochrane’s work in engagement and involvement is evidence based, and to
    monitor and evaluate the impact of its work.



“Cochrane’s importance in the world of evidence-based medicine, its increasingly
global reach, and growing membership, create an opportunity to significantly
develop its work to engage with an international patient and public audience,”
says Catherine Spencer, Cochrane CEO. “This framework ensures that patients,
carers and the public are at the heart of what Cochrane does.” 

Chris Champion, Cochrane's Engagement, Learning and Support, explains how the
framework fits in to Cochrane's engagement strategy and how you can get
involved. 



Maureen Smith, Chair of the Cochrane Consumer Network Executive, explains how
the framework fits into Cochrane's engagement strategy and is relevant to
patients, carers, and the public.



 * Read and download ‘Cochrane consumer engagement and involvement framework to
   2027’
 * Visit the Cochrane Consumer Network Website
 * Get involved with Cochrane as a patient or carer

Friday, March 10, 2023
Lydia Parsonson


FEATURED REVIEW: CAN TESTS FOR INFLAMMATION HELP DOCTORS DECIDE WHETHER TO USE
ANTIBIOTICS FOR AIRWAY INFECTIONS?

Cochrane News
2 years 1 month ago
Monday, October 17, 2022
Lydia Parsonson


PERIODIC CHANGE OF BODY POSITION UNDER PHOTOTHERAPY IN TERM AND PRETERM NEONATES
WITH HYPERBILIRUBINAEMIA

Cochrane News
2 years 2 months ago
Thursday, October 13, 2022
Paolo Rosati


TWO KEY OPPORTUNITIES TO INFORM GLOBAL CLINICAL TRIAL POLICY: ADD YOUR VIEWS

Cochrane News
2 years 2 months ago

The World Health Organization (WHO) is currently running two consultations which
will shape the future of global clinical trials policy. We encourage the
Cochrane Community to participate. 

The surveys are being carried out following the passing of a resolution on
‘strengthening clinical trials to provide high-quality evidence on health
interventions and to improve research quality and coordination’ at the World
Health Assembly in May 2022.

Cochrane is submitting responses to both consultations at the central level. We
also encourage members of our community who work with clinical trial data to
also take part and share their perspectives.

Consultation 1: World Health Assembly Resolution on strengthening clinical
trials

This survey requests input on implementation of the clinical trials resolution
on a wide range of issues related to trials including data sharing, ensuring
more representative trial populations, and planning and conducting trials in
emergency circumstances. This is an opportunity to share examples of best
practice and recommendations for improvement. The questions are available in PDF
form here to help with preparing responses.

Consultation 2: WHO International Clinical Trials Registry Platform – draft
guidance on reporting results in trial registries

This survey is a key opportunity to ensure that the reporting of results in
clinical trial registries are fit for purpose. It concerns recommendations on
the minimum elements of studies which should be reported. The questions are also
available in PDF form here to help with prepare responses.

Both consultations close on 11 November 2022 – please consider participating.

If you are interested in finding out more about and contributing to Cochrane’s
advocacy in this area, please write to Emma Thompson, Cochrane’s Advocacy and
Partnerships Lead.

Wednesday, October 12, 2022
Muriah Umoquit


COCHRANE GOVERNING BOARD ANNOUNCES NEW TRUSTEES - EMBEDDING EVIDENCE AND
GOVERNANCE EXPERTISE INTO COCHRANE’S GOVERNING BOARD

Cochrane News
2 years 2 months ago

Cochrane appointments of two new governing board members, Professor Gillian
Leng and Professor Wendy Levinson and says farewell to two retiring
Trustees, Rae Lamb and Marguerite Koster.

Cochrane is an international non-profit network, which sets the gold standard
for synthesizing health research findings  to facilitate evidence-based health
care.  Cochrane Reviews, found in the Cochrane Library, are up-to-date, follow a
rigorous scientific methodology, and are free from commercial conflicts of
interest. Health professionals, patients, and policy makers trust Cochrane
Reviews for their healthcare decision-making. Cochrane works with researchers,
health professionals, patients, policy makers, and media representatives from
around the world to make Cochrane Reviews relevant and usable.

Cochrane's Governing Board is responsible for setting Cochrane's strategic
direction and overseeing the work of the Chief Executive Officer, Editor in
Chief, and Central Executive Team. Tracey Howe has recently been appointed for a
second term as Co-Chair of the Cochrane Governing Board.  Along with Co-Chair,
Catherine Marshall, Tracey Howe,  announced the appointment of two new governing
board members, Professor Gillian Leng and Prof essor Wendy Levinson and farewell
to two retiring Trustees, Rae Lamb and Marguerite Koster.



Gillian Leng, former Chief Executive of the National Institute for Health and
Care Excellence (NICE), and current trustee of the Guidelines International
Network, has over 30 years’ experience of working within the national and
international worlds of guideline development and associated evidence and
research functions. Her knowledge and understanding of the development and use
of evidence based health advice, in the Uk and internationally, will be valuable
as the Cochrane Board continues its work developing a secure and strong role for
the future.

Gill Leng said, "Cochrane is hugely important for international healthcare and
plays a vital function in ensuring effective, robust evidence is available at a
global level. As the trend for ‘living guidelines’ increases, the role of
Cochrane as an evidence provider will become ever more essential, bringing
alignment where appropriate with the needs for guideline developers. I have been
a strong ‘Evidence advocate’ since I was a junior doctor, I contributed as a
Cochrane Editor for many years, and I welcome the opportunity to help shape the
future of Cochrane."



Wendy Levinson, is a Professor of Medicine at University of Toronto, currently
Chair of Choosing Wisely Canada. She has a wide range of experience from her
volunteer roles as Chair or President of the boards of the American Board of
Internal Medicine, the Society of General Internal Medicine, the Professors of
Medicine, and the Canadian Association of Professors of Medicine and full-time
positions including serving as the Chair of Medicine at the University of
Toronto  and the Division head of General Internal Medicine and Geriatrics at
the University of Chicago. 

Wendy Levinson said of her appointment, "I admire the work of Cochrane and use
the reviews frequently. Cochrane is undergoing major changes and I look forward
to using my skills in leadership of large organizations, strategic planning, and
fundraising to help support Cochrane’s future. Furthermore, my international
network through Choosing Wisely may also serve to support Cochrane and build a
useful collaboration, especially as we continue our important work identifying
low value health care."

Catherine Spencer, Cochrane CEO said, ‘Wendy and Gill both bring an inspiring
range of professional experience, which we welcome to help us navigate a new
future for Cochrane. Both new Trustees also bring links with organisations
Cochrane has partnered with and that rely on Cochrane Evidence for their work –
the Guidelines International Network and Choosing Wisely.

We would also like to warmly thank leaving Trustees, Rae Lamb and Marguerite
Koster for their service to and support for Cochrane.



Rae Lamb, is the Chief Executive of Te Pou in NZ, a national centre for
workforce and leadership development for the mental health workforce in New
Zealand, specialising in the development of evidence-based mental health
resources and Deputy Chair of the NZ Quality and Safety Commission.  Ms Lamb
initially trained as a reporter and broadcaster, then undertook a Harkness
Fellowship in Health Policy at the Harvard School of Public Health and Institute
for Healthcare Improvements in the United States. Rae has also served as a
former New Zealand Deputy Health and Disability Commissioner and Australian Aged
Care Complaints Commissioner.

Catherine Marshall, Co-Chair, said "Rae brought a wealth of experience in
governance, organisational leadership, change management, complaint resolution
and working with diverse stakeholder groups nationally and internationally. Rae
understands the importance of evidence-based health care and decision making,
and her professional, ethical approach has made a significant contribution to
the governing board. We thank her for her work on our Complaints Policy and with
the Complaints Committee and as a member of the Governance Committee."

Rae Lamb said “Cochrane and the work of its community is more important than
ever in this late pandemic world where misinformation is rife. I am humbled to
have had the opportunity to be part of Cochrane. I strongly believe there are
exciting opportunities and times ahead for the organistion, its work and its
people.”



Marguerite Koster,  Director of Evidence-Based Medicine at Kaiser Permanente
Southern California, one of the largest not-for-profit health plans in the U.S.,
serving 12.2 million members. She oversees the efforts of the Southern
California Permanente Medical Group’s Evidence-Based Medicine Services Unit
within Kaiser Permanente’s Southern California Region, which provides medical
care to more than 4.5 million members.   Marguerite will continue to serve
Cochrane as a member of the Future of Evidence Synthesis Oversight Committee.

Tracey Howe, Co-Chair Governing Board, said "Marguerite was appointed to the
Cochrane’s Governing Board in 2016 as one of its first externally appointed
members. Marguerite has played an invaluable role as a Co-Chair of the Governing
Board, Treasurer, Chair of the Finance, Audit & Investment Subcommittee, a
member of the Remuneration and Governance Subcommittees, and the
Cochrane/Guidelines International Network Partnership Advisory Group. Cochrane
has benefited from Marguerite’s valuable experience in using Cochrane evidence
to develop clinical practice guideline development, and inform health technology
assessment, knowledge translation and evidence-based implementation."

Marguerite Koster said,  “Cochrane’s systematic reviews have been invaluable in
informing evidence-based health care decisions within Kaiser Permanente. It has
been my pleasure to serve on the Governing Board, especially to emphasize the
vital role of the Cochrane Library in influencing health care policy and
practice within a large health delivery system.”

 * Learn more about Cochrane's governance and management

Wednesday, October 12, 2022
Muriah Umoquit


WORLD HEALTH ORGANIZATION USES COCHRANE EVIDENCE IN INDUCTION OF LABOUR
RECOMMENDATIONS

Cochrane News
2 years 2 months ago

The World Health Organization (WHO) has issued updated recommendations on the
induction of labour which is supported by evidence from Cochrane Pregnancy and
Childbirth.

WHO develops global health guidelines, which are of a high methodological
quality and are developed through a transparent, evidence-based decision-making
process. Ensuring there is an appropriate use of evidence within these
guidelines, represents one of the core aspects of Cochrane’s collobration with
WHO. Cochrane has been a non-governmental organization in official relations
with WHO since 2011.

The Cochrane Pregnancy and Childbirth Group has a long-standing collaboration
with WHO on the development and updating of Cochrane reviews that inform WHO’s
guidelines on global maternal and perinatal health.


 
The primary goal of the latest guidelines for induction of labour is to improve
the quality of care and outcomes for pregnant women undergoing induction of
labour in under-resourced settings. The target audience of these guidelines
includes obstetricians, midwives, general medical practitioners, health-care
managers and public health policy-makers. The guidance provided is
evidence-based and covers selected topics related to induction of labour that
were regarded as critical priority questions by an international,
multidisciplinary group of health-care workers, consumers and other
stakeholders.

The updated to the recommendation include:

 * Outpatient settings for induction of labour
 * Induction of labour, at or beyond term
 * Mechanical methods for induction of labour



“Cochrane’s official relations with WHO ensures they are able to draw on high
quality evidence in their guidelines and recommendations that will have an
impact upon health policies and clinical practice worldwide,” says Cochrane’s
Editor in Chief, Dr Karla Soares-Weiser. “It’s also a testament to the important
and hard work that many in the Cochrane community are putting forward.”

 * Visit the Cochrane Pregnancy and Childbirth website
 * Read the WHO recommendations for induction of labour

Tuesday, October 11, 2022 Category: The difference we make
Lydia Parsonson


FEATURED REVIEW: HOUSE MODIFICATIONS FOR PREVENTING MALARIA

Cochrane News
2 years 2 months ago

Installing mosquito screening over house windows and closing the gaps in house
eaves can help reduce infection with Plasmodium parasites and the number of
people with anaemia in the household, according to an updated Cochrane Review
published this week. Householders can implement many of these house
modifications themselves, providing a simple malaria prevention tool to
complement existing vector control strategies.

The review author team, from the UK, Spain, South Africa, and Malawi, included
one randomized controlled trial (RCT) and six cluster-RCTs, and noted an
additional six ongoing trials. Trials assessed screening of windows, doors,
eaves, ceilings, or any combination of these; this was either alone, or in
combination with roof modification or eave tube installation (an insecticidal
"lure and kill" device that reduces mosquito entry whilst maintaining some air
flow).




The seven included trials, conducted in sub-Saharan Africa, showed that people
living in modified houses were less likely to have Plasmodium parasites in their
blood, and were less likely to experience moderate or severe anaemia. There was
also a large reduction in the number of mosquitoes trapped indoors at night in
some of the included trials.

This approach is not a new phenomenon; research from 1901 first demonstrated the
effect of simple house screening techniques for protecting families in Italy
from mosquito-related illness, and many householders globally continue to screen
their homes to protect from nuisance insects. House modifications may provide an
important, long-term, sustainable option to reduce malaria.

CIDG Research Associate and lead author Tilly Fox noted, “These results are
encouraging, and the reduction in indoor mosquitoes will mean householders will
be motivated to screen houses simply to reduce the nuisance factor as well as
the health benefits”.

Professor Steve Lindsay from Durham University said, “It is gratifying to see
the protective effect of house screening against malaria in different sites. For
the future, innovative new solutions are needed to provide better and
longer-lasting protection, including tougher screened windows, self-closing
doors, and re-designing housing which will help keep the occupants healthy,
comfortable, and secure.”





 * Read the full review and plain language summary here
 * Visit the Cochrane Infectious Diseases Group here

Fox T, Furnival-Adams J, Chaplin M, Napier M, Olanga EA. House modifications for
preventing malaria. Cochrane Database of Systematic Reviews 2022, Issue 10. Art.
No.: CD013398. DOI: 10.1002/14651858.CD013398.pub4.

Article originally published on Liverpool School of Tropical Medicine website

Friday, October 7, 2022
Lydia Parsonson


COCHRANE SEEKS DIRECTOR OF PUBLISHING AND TECHNOLOGY - UK, REMOTE

Cochrane News
2 years 2 months ago

Specifications: Full Time (Permanent role)
Salary: £85,000 per annum
Location: UK, homebased and remote-working (attendance at meetings will be
expected to pursue development and build relations)
Application Closing Date:  Wednesday 19 October 2022, 9am GMT

Cochrane aims to put evidence at the heart of health decision-making globally.
We collaborate to produce trusted synthesized evidence, make it accessible to
all, and advocate for its use.   Cochrane is seeking a Director of Publishing
and Technology.

Cochrane is a charity and a global, independent network of health practitioners,
researchers, patient advocates and others, responding to the challenge of making
vast amounts of research evidence useful for informing decisions about health.
They do this by synthesising research findings to produce the best available
evidence on what works. Their work has been recognised as the international gold
standard for high quality, trusted information.

As a member of the Executive Leadership Team, this role will lead the Publishing
and Technology Directorate (comprising Cochrane Library partnership, Informatics
and IT Services, product and business development) to drive high performance,
organizational growth and financial returns to Cochrane.

Cochrane is seeking an ambitious individual who relishes a challenge, loves
collaborative working, delivers results and has experience of successfully
delivering strategy. The ideal candidates will possess an understanding and
experience of leading the management and development of a portfolio of products
and services that are appropriately priced to generate income.  You will support
Cochrane to navigate a sustainable and realistic route to Open Access
publishing, working with the leadership team, expert advisers, the Governing
Board and our publisher (Wiley). Finally, you will be enterprising and a
strategic thinker with the ability to seek and find creative solutions and
foster innovation in your teams.

Cochrane welcomes applications from a wide range of perspectives, experiences,
locations and backgrounds; diversity, equity and inclusion are key to their
values.



How to apply

To obtain the candidate pack and further information on how to apply please
contact:

Abigail Barclay
Search Director
a.barclay@inspiredselection.com

PLEASE NOTE: The recruitment agency will be longlisting applications as soon as
they receive them, so please apply early to register your interest. 



Thursday, October 6, 2022 Category: Jobs
Muriah Umoquit


THE ROBERT WOOD JOHNSON FOUNDATION AWARDS $1M TO TEXAS CHRISTIAN UNIVERSITY
TOWARDS THE COCHRANE US NETWORK

Cochrane News
2 years 2 months ago

Funding will support the centering of racial health equality in systematic
reviews through national consensus building.

The Robert Wood Johnson Foundation (RWJF) is the largest American philanthropic
organization focused solely on health and healthcare. The recent grant of $1
Million awarded to members and partners of the Cochrane US Network, including
Texas Christian University (TCU), RTI International, Campbell Collaboration,
Marymount University, and Georgia College, will support critical research to
center racial health equity in systematic reviews through national consensus
building.  

RWJF defines health equity to means that everyone has a fair and just
opportunity to be as healthy as possible, which requires removing obstacles to
health such as poverty, discrimination, and their consequences.  Systematic
reviews—rigorous and comprehensive syntheses and critical appraisal of
evidence—is a gold standard research tool to improve dissemination of
evidence-based practices that can reduce or eliminate disparities.  To date,
guidance documents for systematic reviews have not routinely considered health
equity when- selecting topics, considering outcomes, conducting critical
appraisal, assessing applicability of evidence to specific populations or
settings, nor when communicating findings to key stakeholders and communities.



Cochrane Senior Officer Us Network, Tiffany Duque, states “by establishing
standards to improve the methods, conduct, and reporting of systematic reviews
specific to racial health equity, Cochrane can help reduce racial health
disparities in the US. With this Robert Wood Johnson funding we will assess the
gaps in primary and secondary research to help improve and guide future evidence
synthesis toward improved racial health equity.”



This award is the largest to date for the Cochrane US Network, which was
established in 2019. Catherine Spencer, Cochrane CEO states, “Racial health
equality is a priority topic for Cochrane, the US, and globally. We encourage
Cochrane reviews to include explicit descriptions of methods, effects of the
interventions, and ability to reduce inequalities in health and to promote their
applicability to all population groups. Cochrane is proud to lend its leadership
and expertise to this project.”

This prestigious collaboration of investigators and institutions will undertake
a comprehensive and ambitious effort to listen to stakeholders and communities,
perform landscape analyses of existing resources, and prioritize next steps as
the first phase to centering racial health equity in systematic reviews. 
Principal Investigators include awardee Dr. Dru Riddle (TCU), Dr. Meera
Viswanathan (RTI), Dr. Vivian Welch (Campbell), Dr. Patricia Heyn (Marymount),
Dr. Damian Francis (Georgia College), and Tiffany Duque (Cochrane).

 * Visit the Cochrane US Network website
 * Learn more about equity methods at Cochrane

Thursday, October 13, 2022
Lydia Parsonson


ANNOUNCING THE 2023 COCHRANE COLLOQUIUM IN LONDON, UK

Cochrane News
2 years 2 months ago

Cochrane London 2023: Forward together for trusted evidence
4-6 September 2023
Central London, UK

Cochrane is an international non-profit network that provides evidence-based
scientific knowledge to improve healthcare for all people worldwide. Cochrane
Reviews summarise all available research on a specific health question. They are
up-to-date, follow a rigorous scientific methodology, and are free from
commercial conflicts of interest. Health professionals, patients, and policy
makers trust Cochrane Reviews for their healthcare decision-making. Cochrane
works with researchers, health professionals, patients, policy makers, and media
representatives from around the world to make Cochrane Reviews relevant and
usable.

Cochrane holds an annual conference, known as a Colloquium, that brings together
Cochrane researchers, clinical professionals, early career professionals,
patients and carers, policymakers, and anyone interested in evidence synthesis
and evidence-based healthcare. The events are a mix of keynote speakers,
training opportunities, workshops, presentations, and a lively social and
networking atmosphere. They are an exciting opportunity for a community of
evidence synthesis enthusiasts to share, learn, and connect.  

Cochrane was founded 30 years ago in Oxford and to mark this anniversary the
colloquium will be held in the United Kingdom. It will take place at the QEII
Centre in Westminster, Central London, hosted by Cochrane UK. The main programme
will run from the 4th to the 6th of September, with satellite events and
meetings on the 3rd September 2023.



This will be the first time the Cochrane community has come together since 2018
and in recognition of this, it is being designed to celebrate the diverse,
global and cohesive nature of the collaboration that is Cochrane. As in previous
years there will be stipends to make it possible for students, early career
professionals and those from low-and middle-income countries to attend. The
Colloquium theme is forward together for trusted evidence. 



Martin Burton, Director of Cochrane UK, said: “After 30 years of producing and
advocating for the use of high-quality evidence, Cochrane can look back on many
significant achievements.  Now we need to look forward together.”



Catherine Spencer, Cochrane CEO said, “The 2023 Cochrane Colloquium is an event
for everyone with an interest in the use of evidence in healthcare decision
making. We welcome those engaged in evidence production, co-production,
dissemination, implementation and policy making, as well as those making
individual healthcare decisions to join us for this exciting event.”

Registration will open in early 2023. Scientific programme will be announced in
the coming months.

 * Find out more at the Colloquium website
 * #CochraneLondon
 * Press contact: Katie Abbotts, Cochrane UK

Tuesday, October 11, 2022
Muriah Umoquit


EDITORIAL: ACHIEVING SUSTAINABLE HEALTHCARE THROUGH DEPRESCRIBING

Cochrane News
2 years 2 months ago

A new Cochrane Library Editorial  has been published about the overtreatment
with multiple medications and potentially inappropriate medications use in
frail, older adults, and people with multimorbidity. 

The editorial introduces the Cochrane Library Special Collection on
deprescribing which provides a summary of Cochrane Reviews on the topic. This
collection of reviews highlight that deprescribing is likely feasible and safe
and can lead to benefits in prescribing and clinical outcomes. However, they
also highlight significant gaps in the literature and methodological challenges
to both conducting deprescribing studies and systematic reviews of
deprescribing. The editorial calls on the deprescribing research field to focus
on universally accepted standards, definitions, and checklists and work
collaboratively with Cochrane Sustainable Healthcare. 



 * Read the deprescribing editorial 
 * View the Cochrane Library Special Collection on deprescribing 
 * Visit the Cochrane Sustainable Healthcare website
 * Register for free webinar on abandoning existing low-value care practices: 20
   October 2022

Wednesday, October 5, 2022
Muriah Umoquit


FEATURED REVIEW: SURVIVOR, FAMILY AND PROFESSIONAL EXPERIENCES OF INTERVENTIONS
FOR SEXUAL ABUSE AND VIOLENCE

Cochrane News
2 years 2 months ago
Wednesday, October 5, 2022
Lydia Parsonson


MENTAL HEALTH SUPPORT IN THE COMMUNITY FOR REFUGEE CHILDREN AND ADOLESCENTS IN
HIGH-INCOME COUNTRIES

Cochrane News
2 years 2 months ago
Tuesday, October 4, 2022
Paolo Rosati


RECORDING: 2022 COCHRANE LECTURE WITH JIMMY VOLMINK

Cochrane News
2 years 2 months ago

In November 2022 Jimmy Volmink, the 'father of evidence-based medicine in
Africa' and dedicated Cochrane member was the speaker for the 2022 Cochrane
Lecture. 

Cochrane Lectures provide a forum for influential thinkers to deliver
thought-provoking talks on the key challenges for the future Evidence-Based
Medicine.

Cochrane’s vision is for a world in which “decisions about health and care are
informed by high-quality evidence.” As a trusted source of evidence, the
organisation is making a substantial contribution to the realisation of this
ideal. Yet, more can be done to extend Cochrane’s global reach, and enhance its
relevance and impact worldwide. In this year’s Cochrane Lecture, Professor James
"Jimmy" Volmink called for the adoption of global health equity as a strategic
priority for Cochrane, and explored ways this can be actioned through steps such
as prioritising review topics, enabling participation and promoting diversity
and inclusion.

Professor Volmink, the founding Director of the South African Cochrane
Centre has a lifelong unwavering commitment to keep on 'banging the drum about
inequality' to affect real change. Jimmy reflects on his personal and
professional journey in this 'Recommended Dose' podcast.



 * Watch other Cochrane Lecture recordings
 * Professor Volmink on Twitter

Thursday, December 1, 2022
Muriah Umoquit


NATIONAL EYE INSTITUTE AWARDS $5 MILLION FOR COCHRANE EYES AND VISION US PROJECT

Cochrane News
2 years 2 months ago

The award supports critical research to help identify treatments to improve the
lives of people suffering from debilitating eye diseases.

 The National Eye Institute (NEI) has awarded a $5 million grant to Tianjing Li,
PhD, associate professor of ophthalmology at the University of Colorado School
of Medicine, in a continuation of the NEI’s support of the Cochrane Eyes and
Vision US Satellite (CEV US Satellite) at the Sue Anschutz-Rodgers Eye Center.

The award is one of the largest grants the CU Department of Ophthalmology has
received from the NEI and ensures the project will remain on the CU Anschutz
Medical Campus for the next five years.

“We are very grateful for NEI’s continued support in the research we are doing,”
says Li. “It will help us grow new partnerships, produce trustworthy evidence,
and ultimately improve the vision care our patients receive.”

The Cochrane Eyes and Vision (CEV) US Satellite is a team of US-based
researchers and practitioners who review medical literature for content covering
interventions to prevent or treat eye conditions and visual impairments and to
help people adjust to visual impairment or blindness. CEV is a member review
group of the Cochrane US Network, which formed in 2019.  Cochrane Senior Officer
Tiffany Duque states "this grant is an exciting achievement for the US Network,
and we thank Dr. Li for her continued efforts and dedication not only to CEV but
also to the US Network. We look forward to the high-quality evidence that will
result from this grant, and to engaging other US Cochrane Centers in ensuring
national dissemination of this important work."

“Cochrane systematic reviews are published in the Cochrane Library, which
contains high-quality, independent evidence to inform health care
decision-making,” says Li, principal investigator for the CEV US Satellite.
“These reviews are valuable sources of information for those receiving and
providing care, as well as for policymakers and researchers. Our reviews have
been highly cited by national and international practice guidelines.”

Although the reviews are written for health care professionals, each review can
also help to assist patients and the public in making informed health care
decisions. Topics for reviews are identified based on gaps in the literature,
importance of the topics to influence practice, and from interest and
suggestions of patients and experts in the field. Once a review topic has been
identified, Li’s team works with eye doctors to produce the review, which is
then peer reviewed and ultimately published in the Cochrane Library.

 “We are very proud of the program Dr. Tianjing Li has built here in the Sue
Anschutz-Rodgers Eye Center,” says Naresh Mandava, MD, chair of the CU
Department of Ophthalmology and Sue Anschutz-Rodgers Endowed Chair in Retinal
Diseases. “Evidence-based medicine is critical to our understanding of disease
and identifying effective therapies that will ultimately improve the lives of
people suffering from debilitating eye diseases. The Cochrane project centered
here at CU leads the way in this endeavor and we appreciate the National Eye
Institute’s continued support of this important work.”

The project’s mission to promote informed health care decision-making and
research is critical amid the current climate of increasing health care
disparities and growth of health care misinformation from online sources.



“Vision health care should be based on science,” Li says. “In this era of data
deluge, evidence-informed practice is needed more than ever.”

Since 2002, the CEV US Satellite has published more than 120 systematic reviews
and more than 90 methodological papers and book chapters. The project has also
trained more than 120,000 individuals in methods for systematic reviews and has
informed hundreds of clinical practice guidelines in the United States and
internationally.

 * Visit the Cochrane Eyes and Vision website
 * Visit the Cochrane US website

Originally posted on the University of Colorado website

Wednesday, September 28, 2022
Muriah Umoquit


COCHRANE SEEKS PUBLISHING SYSTEMS SUPPORT SPECIALIST

Cochrane News
2 years 2 months ago

Location: Flexible location (remote working) – contract type dependent on
location.
Specifications: Permanent employment contract if successful applicant based in
UK, Germany or Denmark. Consultancy contract in other locations.
Salary: £36,000 per annum
Application Closing Date:  18 October 2022

Cochrane is a charity and a global, independent network of health practitioners,
researchers, patient advocates and others, responding to the challenge of making
vast amounts of research evidence useful for informing decisions about health.
They do this by synthesising research findings to produce the best available
evidence on what works. Their work has been recognised as the international gold
standard for high quality, trusted information.

The core purpose of this role is to ensure that Cochrane systems are presented
coherently to our users, are well-documented, tested, fit for purpose and that
the user voice is heard in system development decision-making.

You will:

 * provide second-line expert support on software used by Cochrane authors and
   staff to write and edit Cochrane Reviews:
   
   * Editorial Manager (third-party software from Aries Systems)
   * project management features in RevMan Web (in-house review development
     software)
 * act as System Administrator for these systems, making configuration changes
   to optimise user experience
 * update supporting documentation and run demos to educate users on system
   configurations
 * input into projects and programmes of work which impact on Cochrane authors
   and staff
 * represent the user voice in system development, based on feedback received
   from support cases and training
 * use your knowledge to influence development priorities and project decisions
   that have an impact on system users

Cochrane welcomes applications from a wide range of perspectives, experiences,
locations and backgrounds; diversity, equity and inclusion are key to their
values.

How to apply

 * For further information on the role and how to apply, please click here.  
 * The deadline to receive your application is by 18 October 2022.  
 * The supporting statement should indicate why you are applying for
 * Read our Recruitment Privacy Statement

Thursday, October 6, 2022 Category: Jobs
Lydia Parsonson

PAGINATION

 * First page « First
 * Previous page ‹ Previous
 * …
 * Page 16
 * Page 17
 * Page 18
 * Page 19
 * Current page 20
 * Page 21
 * Page 22
 * Page 23
 * Page 24
 * …
 * Next page Next ›
 * Last page Last »


SEGUICI

 

 



 
Menu



MAIN NAVIGATION

 * About Us
 * Get Involved
 * News
 * Resources
 * Contact
 * Join Cochrane

 * English
 * Italiano


TOP MENU

 * Cochrane.org
 * Cochrane Library
 * Admin

Cochrane
 * About Cochrane
   * Cochrane.org
   * Who we are
   * Get involved
   * Consumer Network
   * Partners
   * Colloquium
   * In the news
 * Publications
   * Cochrane Library
     * Cochrane Reviews (CDSR)
     * Trials (CENTRAL)
     * Cochrane Clinical Answers
   * Cochrane Evidence Synthesis and Methods
 * Community
   * Community
   * Cochrane Account
   * Training
   * Support
   * Methods
   * Software
   * Jobs and opportunities
 * Contact us
   * General enquiries
   * Cochrane Library support
   * Cochrane Groups
   * Media


Trusted evidence.
Informed decisions.
Better health.

Copyright © 2024 The Cochrane Collaboration
Index | Website Terms & Conditions | Disclaimer | Privacy | Cookie policy |
Cookie settings
We use cookies to improve your experience on our site.OK More information

OUR USE OF COOKIES

We only use cookies that are necessary to enable core functionality such as
security, network management, and accessibility. You may disable these by
changing your browser settings, but this may affect how the website functions.
Clicking on 'OK' will set a cookie on your device to remember you read this
message.
For more detailed information about the cookies we use, see our Cookies page.

OK